跳至主要内容
临床试验/ISRCTN40152556
ISRCTN40152556已完成未知

Oral Rehydration therapy versus IntraVenous rehydration therapy in the first 12 hours following hospitalisation for hyperemesis gravidarum: a multicentre randomised controlled trial

niversity of Malaya Medical Centre0 个研究点目标入组 124 人开始时间: 2020年12月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
124

研究概览

简要总结

2024 Results article in https://doi.org/10.1002/ijgo.15429 (added 16/02/2024)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Aged =18 years
  • 2. Confirmed pregnancy by urine pregnancy test and presence of intrauterine sac
  • 3. Clinical diagnosis of hyperemesis gravidarum, with presence of ketonuria of at least 2+ on admission
  • 4. Gestation age less than 14 weeks
  • 5. First hospital admission for hyperemesis gravidarum, and within 2 h of admission, where rehydration therapy has not formally been commenced

排除标准

  • 1. Allergy to oral rehydration salts
  • 2. Women with an underlying medical disorder (including diabetes mellitus, hypertension, heart disease, renal disease, and endocrine disorder such as hyperthyroid disorder)
  • 3. Multiple pregnancy
  • 4. Proven non viable pregnancy

研究者

发起方
niversity of Malaya Medical Centre

相似试验

Oral versus intravenous rehydration in management of... | 临床试验